Clinical trials of Herceptin(trastuzumab). (Q34135002)

31 July 2017

1 reference

title

Clinical trials of Herceptin(trastuzumab). (English)

1 reference

31 July 2017

J Baselga

1

1 reference

31 July 2017

1 January 2001

1 reference

European Journal of Cancer

31 July 2017

1 reference

31 July 2017

37 Suppl 1

1 reference

31 July 2017

S18-24

1 reference

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

Testing for erbB-2 by immunohistochemistry in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900404-4

7 January 2021

10.1016/S0959-8049(00)00404-4

Identifiers

DOI

1 reference

31 July 2017

1 reference